InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Adimab, LLC. Officer active across 2 companies, notably Adagio Therapeutics, Inc.. Cumulatively, 4 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €18.2m. Activity tracked since 19 January 2024. The latest transaction was filed on 19 January 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
4 of 4 declarations